Effects of vitamin e on peroxisome proliferator-activated receptor γ and nuclear factor-erythroid 2-related factor 2 in hypercholesterolemia-induced atherosclerosis

Free Radical Biology and Medicine

Volumn 70, Issue , 2014, Pages 174-181

  Bozaykut, Perinur ^a   Karademir, Betul ^a   Yazgan, Burak ^a   Sozen, Erdi ^a   Siow, Richard C M ^b   Mann, Giovanni E ^b   Ozer, Nesrin Kartal ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Atherosclerosis; Free radicals; Hypercholesterolemia; Nrf2; PPAR ; Redox signaling; Vitamin E

Indexed keywords

ABC TRANSPORTER A1; ALPHA ACTIN; ALPHA TOCOPHEROL; CD36 ANTIGEN; GLUTATHIONE TRANSFERASE ALPHA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERSTITIAL COLLAGENASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; CHOLESTEROL INTAKE; GLUTATHIONE S-TRANSFERASE ALPHA; GLUTATHIONE TRANSFERASE; ISOENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHEMOLUMINESCENCE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; HYPERCHOLESTEROLEMIA; IMMUNOBLOTTING; IN VIVO STUDY; LIPID STORAGE; MACROPHAGE; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT MODEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ADMINISTRATION AND DOSAGE; ANIMAL; BIOSYNTHESIS; CHOLESTEROL INTAKE; COMPLICATION; DRUG EFFECTS; FAMILIAL HYPERCHOLESTEROLEMIA; GENE EXPRESSION REGULATION; LIPID DIET; METABOLISM; PATHOLOGY; RABBIT; SIGNAL TRANSDUCTION;

ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL, DIETARY; DIET, HIGH-FAT; GENE EXPRESSION REGULATION; GLUTATHIONE TRANSFERASE; HYPERLIPOPROTEINEMIA TYPE II; ISOENZYMES; MALE; MATRIX METALLOPROTEINASE 1; NF-E2-RELATED FACTOR 2; PPAR GAMMA; RABBITS; SIGNAL TRANSDUCTION; VITAMIN E;

EID: 84897848959     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2014.02.017     Document Type: Article

References (55)

1. X.H. Yu, Y.C. Fu, D.W. Zhang, K. Yin, and C.K. Tang Foam cells in atherosclerosis Clin. Chim. Acta 424 2013 245 252
2. R. Ross Atherosclerosis - an inflammatory disease N. Engl. J. Med. 340 1999 115 126
3. B. Catalgol, and N.K. Ozer Protective effects of vitamin E against hypercholesterolemia-induced age-related diseases Genes Nutr. 7 2012 91 98
4. S. Taha, A. Azzi, and N.K. Ozer Homocysteine induces DNA synthesis and proliferation of vascular smooth muscle cells by a hydrogen peroxide-independent mechanism Antioxid. Redox Signaling 1 1999 365 369
5. T.E. Sussan, J. Jun, R. Thimmulappa, D. Bedja, M. Antero, and K.L. Gabrielson et al. Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice PLoS One 3 2008 e3791
6. A.L. Levonen, E. Vahakangas, J.K. Koponen, and S. Yla-Herttuala Antioxidant gene therapy for cardiovascular disease: current status and future perspectives Circulation 117 2008 2142 2150
7. A. Alfieri, S. Srivastava, R.C. Siow, M. Modo, P.A. Fraser, and G.E. Mann Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke J. Physiol 589 2011 4125 4136
8. T. Ishii, K. Itoh, E. Ruiz, D.S. Leake, H. Unoki, and M. Yamamoto et al. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal Circ. Res. 94 2004 609 616
9. T. Ishii, K. Itoh, S. Takahashi, H. Sato, T. Yanagawa, and Y. Katoh et al. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages J. Biol. Chem. 275 2000 16023 16029
10. S. Hyeon, Y. Yang, and W. Jeong Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation Free Radic Biol Med, 65 2013 789 799
11. X. Cheng, R.C. Siow, and G.E. Mann Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway Antioxid. Redox Signaling 14 2011 469 487
12. M. He, R.C. Siow, D. Sugden, L. Gao, X. Cheng, and G.E. Mann Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: a role for Nrf2 in vascular protection in diabetes Nutr. Metab. Cardiovasc. Dis. 21 2011 277 285
13. H. Sawada, Y. Saito, and N. Noguchi Enhanced CD36 expression changes the role of Nrf2 activation from anti-atherogenic to pro-atherogenic in apoE-deficient mice Atherosclerosis 225 2012 83 90
14. B. Barajas, N. Che, F. Yin, A. Rowshanrad, L.D. Orozco, and K.W. Gong et al. NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection Arterioscler. Thromb. Vasc. Biol. 31 2011 58 66
15. S. Sueyoshi, M. Mitsumata, Y. Kusumi, M. Niihashi, M. Esumi, and T. Yamada et al. Increased expression of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma in human atherosclerosis Pathol. Res. Pract. 206 2010 429 438
16. T. Kim, and Q. Yang Peroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular system World J. Cardiol. 5 2013 164 174
17. M. Ogata, M. Tsujita, M.A. Hossain, N. Akita, F.J. Gonzalez, and B. Staels et al. On the mechanism for PPAR agonists to enhance ABCA1 gene expression Atherosclerosis 205 2009 413 419
18. M. Francois, P. Richette, L. Tsagris, M. Raymondjean, M.C. Fulchignoni-Lataud, and C. Forest et al. Peroxisome proliferator-activated receptor-gamma down-regulates chondrocyte matrix metalloproteinase-1 via a novel composite element J. Biol. Chem. 279 2004 28411 28418
19. M.Y. Kuo, H.C. Ou, W.J. Lee, W.W. Kuo, L.L. Hwang, and T.Y. Song et al. Ellagic acid inhibits oxidized low-density lipoprotein (OxLDL)-induced metalloproteinase (MMP) expression by modulating the protein kinase C-alpha/extracellular signal-regulated kinase/peroxisome proliferator-activated receptor gamma/nuclear factor-kappaB (PKC-alpha/ERK/PPAR-gamma/NF-kappaB) signaling pathway in endothelial cells J. Agric. Food Chem. 59 2011 5100 5108
20. N. Marx, G. Sukhova, C. Murphy, P. Libby, and J. Plutzky Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro Am. J. Pathol. 153 1998 17 23
21. A. Azzi, and A. Stocker Vitamin E: non-antioxidant roles Prog. Lipid Res. 39 2000 231 255
22. R. Ricciarelli, J.M. Zingg, and A. Azzi Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells Circulation 102 2000 82 87
23. N.K. Ozer, and A. Azzi Effect of vitamin E on the development of atherosclerosis Toxicology 148 2000 179 185
24. N.K. Ozer, O. Sirikci, S. Taha, T. San, U. Moser, and A. Azzi Effect of vitamin E and probucol on dietary cholesterol-induced atherosclerosis in rabbits Free Radic. Biol. Med. 24 1998 226 233
25. D. Wu, T. Koga, K.R. Martin, and M. Meydani Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes Atherosclerosis 147 1999 297 307
26. A. Munteanu, M. Taddei, I. Tamburini, E. Bergamini, A. Azzi, and J.M. Zingg Antagonistic effects of oxidized low density lipoprotein and alpha-tocopherol on CD36 scavenger receptor expression in monocytes: involvement of protein kinase B and peroxisome proliferator-activated receptor-gamma J. Biol. Chem. 281 2006 6489 6497
27. A. Chawla, W.A. Boisvert, C.H. Lee, B.A. Laffitte, Y. Barak, and S.B. Joseph et al. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis Mol. Cell 7 2001 161 171
28. D.W. Nierenberg, and S.L. Nann A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples Am. J. Clin. Nutr. 56 1992 417 426
29. N.K. Ozer, Y. Negis, N. Aytan, L. Villacorta, R. Ricciarelli, and J.M. Zingg et al. Vitamin E inhibits CD36 scavenger receptor expression in hypercholesterolemic rabbits Atherosclerosis 184 2006 15 20
30. T. Munzel, I.B. Afanas×ev, A.L. Kleschyov, and D.G. Harrison Detection of superoxide in vascular tissue Arterioscler. Thromb. Vasc. Biol. 22 2002 1761 1768
31. M. Dietrich, P.F. Jacques, M.J. Pencina, K. Lanier, M.J. Keyes, and G. Kaur et al. Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: does the underlying health status play a role? Atherosclerosis 205 2009 549 553
32. A. Munteanu, and J.M. Zingg Cellular, molecular and clinical aspects of vitamin E on atherosclerosis prevention Mol. Aspects Med. 28 2007 538 590
33. V.G. Demarco, A.T. Whaley-Connell, J.R. Sowers, J. Habibi, and K.C. Dellsperger Contribution of oxidative stress to pulmonary arterial hypertension World J. Cardiol. 2 2010 316 324
34. A. Gozin, E. Franzini, V. Andrieu, C.L. Da, E. Rollet-Labelle, and C. Pasquier Reactive oxygen species activate focal adhesion kinase, paxillin and p130cas tyrosine phosphorylation in endothelial cells Free Radic. Biol. Med. 25 1998 1021 1032
35. S.P. Forbes, I.S. Alferiev, M. Chorny, R.F. Adamo, R.J. Levy, and I. Fishbein Modulation of NO and ROS production by AdiNOS transduced vascular cells through supplementation with L-Arg and BH4: Implications for gene therapy of restenosis Atherosclerosis 230 2013 23 32
36. G. Tie, J. Yan, Y. Yang, B.D. Park, J.A. Messina, and R.L. Raffai et al. Oxidized low-density lipoprotein induces apoptosis in endothelial progenitor cells by inactivating the phosphoinositide 3-kinase/Akt pathway J. Vasc. Res. 47 2010 519 530
37. M. McMahon, K. Itoh, M. Yamamoto, and J.D. Hayes Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression J. Biol. Chem. 278 2003 21592 21600
38. N. Wakabayashi, K. Itoh, J. Wakabayashi, H. Motohashi, S. Noda, and S. Takahashi et al. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation Nat. Genet. 35 2003 238 245
39. A.T. Dinkova-Kostova, W.D. Holtzclaw, R.N. Cole, K. Itoh, N. Wakabayashi, and Y. Katoh et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants Proc. Natl. Acad. Sci. USA 99 2002 11908 11913
40. M. Kobayashi, L. Li, N. Iwamoto, Y. Nakajima-Takagi, H. Kaneko, and Y. Nakayama et al. The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds Mol. Cell Biol. 29 2009 493 502
41. T. Satoh, S.R. McKercher, and S.A. Lipton Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs Free Radic. Biol. Med. 65C 2013 645 657
42. D. Olagnier, R.A. Lavergne, E. Meunier, L. Lefevre, C. Dardenne, and A. Aubouy et al. Nrf2, a PPARgamma alternative pathway to promote CD36 expression on inflammatory macrophages: implication for malaria PLoS Pathog. 7 2011 e1002254
43. S.J. Chapple, X. Cheng, and G.E. Mann Effects of 4-hydroxynonenal on vascular endothelial and smooth muscle cell redox signaling and function in health and disease Redox Biol. 1 2013 319 331
44. J.Z. Cheng, S.S. Singhal, A. Sharma, M. Saini, Y. Yang, and S. Awasthi et al. Transfection of mGSTA4 in HL-60 cells protects against 4-hydroxynonenal- induced apoptosis by inhibiting JNK-mediated signaling Arch. Biochem. Biophys. 392 2001 197 207
45. S. Kazi, and E.M. Ellis Expression of rat liver glutathione-S-transferase GSTA5 in cell lines provides increased resistance to alkylating agents and toxic aldehydes Chem. Biol. Interact. 140 2002 121 135
46. Y. Yang, Y. Yang, M.B. Trent, N. He, S.D. Lick, and P. Zimniak et al. Glutathione-S-transferase A4-4 modulates oxidative stress in endothelium: possible role in human atherosclerosis Atherosclerosis 173 2004 211 221
47. K. Ranganna, O.P. Mathew, F.M. Yatsu, Z. Yousefipour, B.E. Hayes, and S.G. Milton Involvement of glutathione/glutathione S-transferase antioxidant system in butyrate-inhibited vascular smooth muscle cell proliferation FEBS J. 274 2007 5962 5978
48. J. Hwang, D.J. Kleinhenz, B. Lassegue, K.K. Griendling, S. Dikalov, and C.M. Hart Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production Am. J. Physiol. Cell Physiol. 288 2005 C899 C905
49. C.R. Williams, X. Lu, R.L. Sutliff, and C.M. Hart Rosiglitazone attenuates NF-kappaB-mediated Nox4 upregulation in hyperglycemia-activated endothelial cells Am. J. Physiol. Cell Physiol. 303 2012 C213 C223
50. A.C. Li, K.K. Brown, M.J. Silvestre, T.M. Willson, W. Palinski, and C.K. Glass Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice J. Clin. Invest. 106 2000 523 531
51. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
52. A.A. Kulkarni, T.H. Thatcher, K.C. Olsen, S.B. Maggirwar, R.P. Phipps, and P.J. Sime PPAR-gamma ligands repress TGFbeta-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis PLoS One 6 2011 e15909
53. P.H. Shih, S.L. Hwang, C.T. Yeh, and G.C. Yen Synergistic effect of cyanidin and PPAR agonist against nonalcoholic steatohepatitis-mediated oxidative stress-induced cytotoxicity through MAPK and Nrf2 transduction pathways J. Agric. Food Chem. 60 2012 2924 2933
54. B.H. Lee, W.H. Hsu, Y.Y. Chang, H.F. Kuo, Y.W. Hsu, and T.M. Pan Ankaflavin: a natural novel PPARgamma agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo Free Radic. Biol. Med. 53 2012 2008 2016
55. P.S. Burrage, A.C. Schmucker, Y. Ren, M.B. Sporn, and C.E. Brinckerhoff Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression Arthritis Res. Ther. 10 2008 R139